The Wellcome Trust is funding a new study and clinical trial that will further investigate the effectiveness of cannabidiol (CBD) in treating people with psychosis. Work carried out by Oxford University and King’s College London will look at whether CBD can be used not only to treat established psychosis, but also to prevent the onset of psychosis in people at high risk of developing it.
Is CBD the future of antipsychotic drugs? | News | Wellcome
Licence: All Rights Reserved